Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Kidney Transplantation
Interventions
DRUG

AEB071

DRUG

Mycophenolic Acid

Trial Locations (28)

3010

Inselspital Bern, Bern

4031

Universitatsspital Basel, Basel

8091

Universitätsspital Zürich, Zurich

10117

Universitaetsklinik Charite, Berlin

13353

Klinikum der Humboldt Universitat Charite, Berlin

28041

Hospital 12 de Octubre, Madrid

Complejo Hospitalario Carlos Haya, Málaga

30625

Medizinische Hochschule Hannover, Hanover

31403

CHU de Rangueil, Toulouse

35128

Azienda Ospedaliera di Padova - Universita degli Studi, Padua

40138

Az. Osp. Di Bologna Polici. S. Orsola - Malpighi, Bologna

44035

Hopital Hotel Dieu, Nantes

45122

Universitaetsklinikum Essen, Essen

46017

Hospital Doctor Peset, Valencia

50134

Azienda Opedaliera Careggi - Universita degli Studi, Florence

51109

Staedt. Krankenhaus Koeln-Merheim, Cologne

69120

Univ. - Klinikum Heidelberg, Heidelberg

75015

Hopital Necker, Paris

94270

Hopital Kremlin Bicetre, Le Kremlin-Bicêtre

94143-0780

University of California, San Francisco, San Francisco

44106-5048

University Hospitals of Cleveland, Cleveland

53792-7375

University of Wisconsin Hospital and Clinics, Madison

B3H 1V7

QE II Health Sciences Center, Halifax

08907

Ciutat Santitaria I Univessitaria de Bellvitge, L'Hospitalet de Llobregat

CF14 4XW

University Hospital of Wales, Cardiff

G11 6NT

Western Infirmary, Glasgow

Unknown

Saint George's University of London, London

Manchester Royal Infirmary, Manchester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY